US Patent 10246462 Chemokine receptor modulators and uses thereof
Patent 10246462 was granted and assigned to Flx Bio, Inc. on April, 2019 by the United States Patent and Trademark Office.
All edits
Edits on 4 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 30 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 9 Dec, 2023
Golden AI
Edits made to:
Article (+136 characters)
Article
Patent abstract
Disclosed herein, inter alia, are compounds and methods of use thereof for the modulation of chemokine receptor activity.
Edits on 22 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
102464620
Date of Patent
April 2, 2019
0Patent Application Number
157000400
Date Filed
September 8, 2017
0Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
102464620
Date of Patent
April 2, 2019
0Patent Application Number
157000400
Date Filed
September 8, 2017
0Patent Primary Examiner
Edits on 25 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10246462 Chemokine receptor modulators and uses thereof
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10246462
Date of patent
April 2, 2019
Patent application number
15700040
Date Filed
September 8, 2017
Patent primary examiner
Find more entities like US Patent 10246462 Chemokine receptor modulators and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.